Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy
- PMID: 9426328
- DOI: 10.1023/a:1008248319036
Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy
Abstract
Background: Penile carcinoma is uncommon in Western countries. Here we report on a large series of patients with squamous cell carcinoma (SCC) of the penis, describing prognostic factors, survival and therapeutic results.
Patients and methods: From 1973 to 1993, 102 patients with invasive SCC of the penis were treated at the Institut Gustave-Roussy. Precancerous lesions and conditions associated with penis cancer were analyzed retrospectively. Survival curves were estimated by the Kaplan-Meier method, and groups were compared for outcome by the log rank test for univariate comparisons and by Cox's proportional hazards model for multivariate analysis.
Results: The median age at onset was 58 years. Sixty-nine patients presented with Jackson's stage I disease, 17 with stage II and 15 with stage III. The interval between the manifestation of symptoms and the diagnosis was more than a year in 13.7% of cases. Precancerous lesions were found in 17 (16.6%) patients, and a history of phimosis was noted in 25 (24.5%). In situ and invasive carcinoma were observed together in 17 (16.6%) cases and dysplasia was associated with invasive carcinoma in eight (7.8%) further cases. Conservative treatment was administered whenever feasible. Interstitial brachytherapy was performed alone or associated with limited surgery (local excision or circumcision) in 72 (70.6%) patients. Of the 28 patients with a local relapse, nine have died of their neoplasms (32%) compared to 21 of 28 patients with lymph node relapse (75%). The median follow-up was 111 months. Disease-free survival, disease-specific survival and overall survival were, respectively, 56%, 72% and 63% at five years and 42%, 66% and 50% at 10 years. Age (P = 0.01), the N status (P < 0.00001) or palpable nodes (P < 0.0038), corpus involvement (P = 0.006) and a verrucous histology (P = 0.038) had significant prognostic relevance for survival in the univariate analysis whereas the performance status, T status and Broders' grade did not. In the multivariate analysis only two parameters, involvement of the corpus (P < 0.0001) and palpable nodes (P = 0.009), were singled out as being independent variables influencing survival. A subgroup of nine patients with verrucous histologies were distinguished by their freedom from node involvement. These patients had an excellent prognosis: all are alive and disease-free. Penile integrity was preserved during follow-up in 54 patients (52.9%), 31 of whom are still alive. Of 72 patients treated by a conservative approach including brachytherapy, long-term penile integrity was maintained in 49 (68%).
Conclusion: Corpus involvement and clinically palpable nodes are highly statistically significant independent factors influencing overall survival. Node relapses remain a major cause of death. Thus, better management of lymph nodes is essential for improving survival even when conservative therapy is used to treat the primary.
Similar articles
-
Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis.Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):713-22. doi: 10.1016/s0360-3016(97)00068-0. Int J Radiat Oncol Biol Phys. 1997. PMID: 9240637
-
Contemporary management of regional nodes in penile cancer-improvement of survival?J Urol. 2014 Jan;191(1):68-73. doi: 10.1016/j.juro.2013.07.088. Epub 2013 Aug 2. J Urol. 2014. PMID: 23917166
-
Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome.Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):563-570. doi: 10.1016/j.ijrobp.2017.02.090. Epub 2017 Feb 28. Int J Radiat Oncol Biol Phys. 2017. PMID: 28501419
-
[Squamous cell carcinoma of the penis: treatment protocol according to our 14 years of experience].Arch Esp Urol. 1997 Jun;50(5):473-80. Arch Esp Urol. 1997. PMID: 9382589 Review. Spanish.
-
[Diagnosis and therapy for penile cancer: a report of 46 cases with literature review].Ai Zheng. 2008 Sep;27(9):962-5. Ai Zheng. 2008. PMID: 18799036 Review. Chinese.
Cited by
-
Updates in the use of radiotherapy in the management of primary and locally-advanced penile cancer.Asian J Urol. 2022 Oct;9(4):389-406. doi: 10.1016/j.ajur.2022.05.010. Epub 2022 Sep 9. Asian J Urol. 2022. PMID: 36381600 Free PMC article. Review.
-
Comparative study of perioperative and survival outcomes after video endoscopic inguinal lymphadenectomy (VEIL) and open inguinal lymph node dissection (O-ILND) in the management of inguinal lymph nodes in carcinoma of the penis.J Robot Surg. 2021 Dec;15(6):905-914. doi: 10.1007/s11701-020-01189-x. Epub 2021 Jan 23. J Robot Surg. 2021. PMID: 33484414
-
Penile cancer: current therapy and future directions.Ann Oncol. 2013 May;24(5):1179-89. doi: 10.1093/annonc/mds635. Epub 2013 Jan 4. Ann Oncol. 2013. PMID: 23293117 Free PMC article. Review.
-
Radiation therapy in the management of the primary penile tumor: an update.World J Urol. 2009 Apr;27(2):189-96. doi: 10.1007/s00345-008-0309-5. Epub 2008 Jul 18. World J Urol. 2009. PMID: 18636264
-
High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis.Clin Transl Radiat Oncol. 2021 Jan 17;27:89-95. doi: 10.1016/j.ctro.2020.12.008. eCollection 2021 Mar. Clin Transl Radiat Oncol. 2021. PMID: 33537466 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials